AbbVie has entered into clinical research collaboration with Tolero Pharmaceuticals to assess the potential benefits of venetoclax and alvocidib combination in relapsed/refractory acute myeloid leukemia (AML)
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,